Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 5, Issue 5 (2016)

Egfr Augments Aerobic Glycolysis In Multi-Negetive Breast Cancer Cells to Promote Tumorigenesis and Immune Escape

Author(s):
Dr D N Tibarewala, Dr Partha Majumder, Dr Anjana Mazumdar, Dr Sukumar Roy, Dr Veera Talukdar
Abstract:
Cellular metabolism and bioenergetics are regulated by cancer genes and are intimately linked to the growth and survival of cancer cells. Metabolism generates oxygen radicals, which contribute to oncogenic mutations. Activated oncogenes and loss of tumor suppressors in turn alter metabolism and induce aerobic glycolysis. Aerobic glycolysis or the Warburg effect links the high rate of glucose fermentation to cancer. Together with glutamine, glucose via glycolysis provides the carbon skeletons, NADPH, and ATP to build new cancer cells, which persist in hypoxia that in turn rewires metabolic pathways for cell growth and survival. Excessive caloric intake is associated with an increased risk for cancers, while caloric restriction is protective, perhaps through clearance of mitochondria or mitophagy, thereby reducing oxidative stress. Hence, the links between metabolism and cancer are multifaceted, spanning from the low incidence of cancer in large mammals with low specific metabolic rates to altered cancer cell metabolism resulting from mutated enzymes or cancer genes.
Pages: 01-08  |  1679 Views  128 Downloads


The Pharma Innovation Journal
How to cite this article:
Dr D N Tibarewala, Dr Partha Majumder, Dr Anjana Mazumdar, Dr Sukumar Roy, Dr Veera Talukdar. Egfr Augments Aerobic Glycolysis In Multi-Negetive Breast Cancer Cells to Promote Tumorigenesis and Immune Escape. Pharma Innovation 2016;5(5):01-08.

Call for book chapter